Company Analysis

Perspective Therapeutics, Inc. (CATX)

NYSE: CATX · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 1995
Grade3.9
◀ Past 3.6● Present 3.9▶ Future 4.2
2 est.

Who runs Perspective Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Spoor Johan M.
Chief Executive Officer. First filing Feb 2023, latest Nov 12, 2026, 5 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
21 people on the record since 2006
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Spoor Johan M.Chief Executive OfficerFeb 2023Nov 12, 2026none
Woods Lori ACEOMar 2007Mar 4, 2026none
Hunt Jonathan RobertChief Accounting OfficerSep 2006Mar 4, 2026none
Puhlmann MarkusChief Medical OfficerFeb 2023Mar 4, 2026none
Sendek JoelChief Financial OfficerSep 2025Sep 5, 2025none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Henson HeididirectorJun 2023Mar 4, 2026none
Martinez Maria EdirectorSep 2025Mar 4, 2026none
Morich FrankdirectorFeb 2023Mar 4, 2026none
Williamson Robert F IIIdirectorMar 2023Mar 4, 2026none
Owners of more than 10% of a classsales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Lantheus Alpha Therapy, LLC10% ownerFeb 2024Sep 8, 20264 · $1.1M
Lantheus Holdings, Inc.10% ownerFeb 2024Sep 8, 20263 · $500,000
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CATX · research, not advice